Alcohol and Innate Immunity
The Effects of Binge Drinking on Innate Host Defence Mechanisms
1 other identifier
observational
46
1 country
1
Brief Summary
Alcohol leads to a leaky gut and translocation of bacterial products. This may lead to inflammation and immune dysfunction as well as the typical hangover symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2015
CompletedFirst Posted
Study publicly available on registry
October 6, 2015
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 22, 2019
CompletedMay 15, 2020
May 1, 2020
2.2 years
July 29, 2015
May 14, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Endotoxin assessed by percentage of endotoxin positive subjects
Endotoxin measured by a HEK-blue cell based assay
4 hours
Secondary Outcomes (7)
gut permeability (zonulin in stool)
4 hours
bacterial translocation (bacterial DNA in serum)
4 hours
oxidative stress (advanced oxidation protein products)
4 hours
inflammation (neutrophil oxidative burst)
4 hours
neutrophil phagocytic capacity
4 hours
- +2 more secondary outcomes
Study Arms (4)
Alcohol binge
Healthy volunteers receive 2ml vodka 40% per kg bodyweight as a binge
Fructose
75 g Fructose orally
Glucose
75 g Glucose orally
Vehicle
2ml tap water per kg body weight
Interventions
Eligibility Criteria
Healthy volunteers selected from a database
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study.
- Age above 18 years
- Willingness to abstain from alcohol 48h prior to the study visits
You may not qualify if:
- Alcohol abuse .Alcohol Use Disorders Identification Test ≥ 8 in men or ≥ 7 in women or CAGE test ≥ 2 (both men and women)
- Elevated liver function test
- Any disease or medication that does not allow concomitant consumption of alcohol
- Women: pregnancy and lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Internal Medicine, Medical University of Graz
Graz, 8010, Austria
Biospecimen
Serum, Plasma, Urine, Stool
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vanessa Stadlbauer, MD
Medical University of Graz
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2015
First Posted
October 6, 2015
Study Start
December 1, 2016
Primary Completion
February 22, 2019
Study Completion
February 22, 2019
Last Updated
May 15, 2020
Record last verified: 2020-05